Physician profile
Brynn S Wolff
NPI 1225246150
$1,152.94
in general payments reported to CMS, 2019-2025
11 companies · $182 in 2025
The $182 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.07 · 2020: $185 · 2022: $364 · 2023: $144 · 2024: $208 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $535.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Molli Surgical (US) INC | $238.50 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $135.51 | 2024 | |
| Hologic Sales and Service, LLC | $131.49 | 2025 | Magtrace |
| Gilead Sciences, INC. | $125.00 | 2022 | |
| Merck Sharp & Dohme LLC | $120.82 | 2023 | Keytruda |
| Astrazeneca Pharmaceuticals LP | $108.23 | 2020 | |
| Kerecis Limited | $101.65 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Mallinckrodt Hospital Products INC. | $77.01 | 2020 | |
| Mallinckrodt Enterprises LLC | $69.07 | 2019 | |
| Medtronic, INC. | $23.59 | 2023 | Plasmablade(Tm) |
| Ge Healthcare | $22.07 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brynn Wolff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.